Societe de Therapeutique Marocaine (SOT.CS)

Also known as:  Sothema
Data delayed by 15 minutes
1,643.00 MAD 0.000.00%
As of 17 AUG 2020 13:30 GMT|Casablanca SE

Sothema Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
4.08%
P/E (Last 12 Month)
12.9
Upside
-
Target Price (Mean)
-
52Wk
1526.0 28 JAN
1709.0 09 JUL

Open
Data not available
Previous Close
1,643.00 MAD
Turnover
Data not available
EPS
127.34 MAD
Volume
0
Transactions
0
Market Cap
2.96B MAD
IPO Date
21-Feb-2005
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Societe de Therapeutique MarocaineLast updated on: 23 June 2020

Business Summary
Production of branded drugs; distribution of personal care products and cosmetics; provides healthcare support services.
Country of Incorporation
Ownership Type
Established In
1976
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
SOT.CSEOrdinaryMADCasablanca SESOT

Contact details

Primary address
Bousoukra Center
Bouskoura Industrial Area
20180
Morocco
Casablanca
CONTACT
  • Tel: +212 522-437040
  • Tel: +212 522-320101
  • Fax: +212 522-334109
  • Email: www.sothema.com
Region
Greater Casablanca
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Mr Omar Tazi
Chief Executive Officer
Mrs Lamia Tazi
General Manager
Mr Mounir Haritane
Internal Audit, Control and Risk Director

Board Members

Mrs Lamia Tazi
Chairperson
Mr Mohammed Rachid Kadiri
Board Secretary
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
PROMOPHARM721.000 MAD0.00
More

Monday Outlook: Dollar firms over new U.S. coronavirus aid package; oil prices drop

Monday Outlook: Dollar firms over new U.S. coronavirus aid package; oil prices drop

US has recorded its highest ever number of new COVID-19 cases for two consecutive days

More

Most Viewed Stocks

Stock Screener

More